Urolog. pro Praxi, 2004; 3: 125-126

Lymfomy varlat

MUDr. Pavla Toufarová1, doc. MUDr. Milan Hora Ph.D1, MUDr. Ludmila Boudová Ph.D2, doc. MUDr. Ondřej Hes Ph.D2, MUDr. Miroslava Schützová3, MUDr. Pavel Jindra3, MUDr. Romuald Čuřík4,5
1 Urologická klinika, FN a LF UK, Plzeň
2 Šiklův patologicko-anatomický ústav, LF UK a FN v Plzni
3 Hematologicko-onkologické oddělení, FN Plzeň
4 Ústav patologie, FNsP Ostrava
5 Dětské oddělení nemocnice s poliklinikou, Třinec

Keywords: testicular lymphomas, diffuse large B cell lymphoma, management approach.

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Toufarová P, Hora M, Boudová L, Hes O, Schützová M, Jindra P, Čuřík R. Lymfomy varlat. Urol. praxi. 2004;5(3):125-126.

Testikulární lymfomy jsou velmi vzácné, prognosticky závažné, představují méně než 1 % všech lymfomů. Vyskytují se u mužů kolem 60 let věku, ojediněle mladších. Histologicky se nejčastěji jedná o difuzní velkobuněčný B-lymfom. Léčba spočívá v provedení vysoké inguinální orchiektomie s následnou chemoterapií zahrnující doxorubicin, cyclofosfamid, vincristin, kortikoidy a radioterapií.

TESTICULAR LYMPHOMAS

Testicular lymphomas are very rare and prognostically relevant. They represent less than 1 % of all lymphomas. They occure in men over the age of 60, only rarely in younger. The most common histological type is diffuse large cell B-lymphoma. The management approach consists of high inguinal orchiectomy followed by chemotherapy including doxorubicin, cyclophosphamide, vincristine, corticoids and radiotherapy.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abrahámová J. Nádory varlat, Trendy v medicíně. 2002; 2: 58-59s.
    2. Abrahámová J. Nádory varlat, Postgrad. Medicína, 2003; 5, č.6: 14s.
    3. Adam Z, Vorlíček J, et al. Hematologie II. Grada Publishing Praha 2001; 201-214.
    4. Boudová L, Hes O, Černá K, Klečka J, Hora M, et al. Lymphomas of the testis, 2003 (připravováno pro tisk).
    5. Clemens JQ, Pins MR. Nonhodgin´s lymphoma presenting as bilateral testicular and adrenal masses, J Urol. 2000; 163: 241-242s. Go to original source... Go to PubMed...
    6. Connors JM. Problems in Lymphoma management: special sites of Presentation, Oncology 1998; 2: 5-7s.
    7. Horňák M, Matoška J. Nádory testis diagnostika a liečba, Veda Bratislava 1990: 98-100.
    8. Isaacson PG, Norton A. Extranodal Lymphomas. Churchill Livingstone,Medical Division of Longman Group Limited, New York 1994: 1.
    9. Klener P. Klinická onkologie, Galén Praha 2002; 105-106, 586-588, 598. Go to original source...
    10. Moertel Cl, Watterson J, Mc Cormick SR, Simonton SC. Follicular large cell lymphoma of the testis in a child Cancer, 1995; 75: 1182-6s. Go to original source... Go to PubMed...
    11. Perez CA, Brady LW. Principles And Practice OF Radiation Oncology, Lippincot, Philadelphia 1992: 1334-1335.
    12. Salem YH, Miller HC. Lymphoma of genitourinary tract, J. Urol. 1994; 151: 1162-1170. Go to original source... Go to PubMed...
    13. Ulbright TM,Amin MB, Young RH. Tumor of the testis, adnexa, spermatic cord, and scrotum, Armed Forces Institute OF Pathology, Washington D.C. 1999: 272-276.
    14. Zucca E, Conconi A, Mughal TI, et al. Patterns of Outcome and Prognostic Factors in Primary Large - Cell Lymphoma of the Testis in a Survey by International Extranodal Lymphom Study Group, J.of Clinical Oncology, 2003; 1, 20-27s. Go to original source... Go to PubMed...
    15. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoetic and lymphoid Tissues. Edited by Jaffe ES, Harris NL, Stein H, Wardiman JW. IARC Press. Lyon, 2001; 121-126, 171.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.